Abstract--Inasmuch as the recruitment of polymorphonuclear leukocytes (PMNs) to inflammatory foci in vivo involves adhesion-dependent events (e~g., margination, diapedesis, and directed migration), we sought to characterize the relationship between the local accumulation of PMNs in sterile peritonitis and their surface expression of the adhesion-promoting plasma membrane glycopmtein, Mol (CD1 lb/ CD18). In an immunofluorescence analysis of PMNs isolated from rats injected intraperitoneally with sterile 1% glycogen solution, we detected a significant enhancement of surface Mol expression by exudative peritoneal PMNs. In contrast, no significant rise in Mol expression was noted over time by circulating intravascular PMNs (isolated simultaneously). However, these intravascular PMNs had the capacity to increase their surface Mol density upon exposure to peritoneal fluid supernatant at 37~ These results demonstrate that PMNs at sites of inflammation in vivo do up-modulate their surface expression of the adhesion-promoting Mol glycoprotein during their recruitment from the circulating, intravascular leukocyte pool.
INTRODUCTION
The recruitment of polymorphonuclear leukocytes (PMNs) from the intravascular compartment to extmvascular sites of inflammation is a characteristic feature of the acute inflammatory response (reviewed in 1, 2) . This accumulation of PMNs in vivo, stimulated by soluble chemotactic factors (1-3), appears to
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be accompanied by several cellular activation events including degranulation (4, 5) and alterations in cellular responsiveness to stimulated superoxide production (5, 6) , membrane depolarization (5) , and chemotaxis (5, (7) (8) (9) . When enhanced, these effects may in part be due to the up-modulation of surface FMLP receptor expression (5) . Another PMN activation event of particular interest in the inflammatory response is the up-modulation of cell surface Mol receptor density. Mol (CDllb/CD18) is a leukocyte plasma membrane glycoprotein that promotes PMN adhesive functions, as demonstrated in vitro by the use of specific inhibitory routine anti-Mo 1 monoclonal antibodies (reviewed in 10) , and by the recognition of an inherited disorder in which PMNs from affected persons are deficient in Mol expression and exhibit markedly impaired cellular adhesive functions (reviewed in 10, 11) . PMN surface Mol expression, in concert with various cellular adhesive properties, is enhanced in vitro in response to exposure to soluble activating factors, including FMLP (12, 13) , C5a (14-16), LTB4 (17, 18) , adenine nucleotides (19) , PMA, and calcium ionophore A23187 (12, 20, 21) , and others. While it has been suggested that PMN Mol receptor up-modulation may occur in vivo (5, 14, (22) (23) (24) , little is known about how this up-modulation might relate to the kinetics of PMN recruitment during inflammation.
Therefore, we undertook this study of an animal model of sterile peritonitis to more fully characterize the PMN response to localized acute inflammation, as manifested by the surface expression of the Mol glycoprotein. The results herein demonstrate that there is a rapid, significant, and sustained up-modulation of surface Mol glycoprotein, which accompanies the accumulation of PMNs at sites of inflammation in vivo, lending further support to the notion that PMNs undergo cellular activation during inflammatory recruitment.
MATERIALS AND METHODS
Reagents. The following reagents were purchased from Sigma Chemical Company (St. Louis, Missouri): ammonium chloride (NH4C1, A4514), disodium ethylene-diaminetetraacetate (EDTA, ED2SS), and glycogen type II (derived from oyster, G8751). Sodium bicarbonate (NaHCO3, 15421) was obtained from Columbus Chemical Industries, Inc. (Columbus, Wisconsin). Fluoreseein isotbiocyanate-conjugated goat anti-mouse IgG -t-IgM antibodies were obtained from Tago, Inc. (6253, Burlingame, CA).
Solutions. Phosphate-buffered saline (PBS, without calcium or magnesium) and Dulbecco's PBS (DPBS) were mixed according to standard formulations using reagent grade chemicals. NH4CI erythrocyte lysis buffer consisted of Nt-I4C10. t5 M, NaHCO3 0.01 M, and EDTA 0.001 M (adjusted to pH 7.20) .
Isolation of Peritoneal Elicited and Intravascular PAINs. Pathogen-free, male, outbred Long-Evans rats weighing 400-450 g were purchased from the Charles River Company (Bar Harbor, Maine). For each experiment, five rats were injected intraperitoneally (under ether anesthesia) with 30 ml of sterile 0.9 % NaC1 solution containing 1% (w/v) glycogen and then allowed to recover from anesthesia. Thereafter, at intervals of 1, 2, 3, 4, and 16 h following the injection, one rat was killed (by cardiac puncture under ether anesthesia), its peritoneal cavity opened, and the fluid therein collected and combined with two subsequent peritoneal washings using 0.9% NaC1 solution. These elicited peritoneal cells were then pelleted, subjected to NH4C1 erythrocyte lysis, washed, and resuspended at 10 x 106 cells/ml in immunofluorescence wash buffer (21) at 4~ prior to staining with monoclonat reagents. Five milliliters of heparinized whole blood obtained from each rat at the time of cardiac puncture was subjected to NH~CI erythrocyte lysis (one part blood to eight parts NH4C1 buffer at 25~ for 5-10 minutes). The leukocytes were then washed twice with PBS and suspended in DPBS prior to in vitro stimulation. Each experiment also included a control animal (anesthetized but not injected with glycogen) from which blood was obtained at time 0, as described above. Total and differential leukocyte counts were determined morphologically using Wright-Giemsa-stained intravascular and peritoneal specimens. Absolute PMN counts were calculated as the percentage of the total leukocyte count comprising segmented and band forms.
Collection of Peritoneal Fluid Supernatant (PFS).
Two rats were injected intraperitoneally with sterile 0.9% NaC1 solution containing 1% glycogen, as described above. After 4 h, approximately 15 ml of intraperitoneal fluid were collected from each rat and subjected to high-speed centrifugation to pellet suspended cells. Aliquots of the resulting cell-free PFS were stored at -80~ until used for in vitro stimulation of isolated, intravascular PMNs.
In Vitro Stimulation of PMNs. Isolated leukocytes harvested at each time point were suspended at 4-12 x 106/ml in DPBS and placed in polypropylene culture tubes (Falcon Plastics, Oxnard, California). Cells were then exposed to an equal volume of undiluted PFS and incubated at 37~ for 30 rain. Control cells received an equal volume of DPBS and were incubated for 30 min at either 37~ or 4~ Cells were then diluted in ~ce-cold PBS, pelleted, and resuspended in immunofluorescence wash buffer (21) prior to further analysis. PMNs were subjected to indirect immunofluoreseence staining for the expression of the Mol (CD1 Ib) antigenic determinant relative to background staining by the isotype identical negativecontrol antibody, anti-Mo2 (anti-CD14), and examined by flow cytometric analysis as described (21, 27) . For experiments shown in Table 2 , specific fluorescence intensity represents the computed mean channel number (0-230 channels, linear scale) c~f cells stained with the anti-Mol reagent minus the mean channel number of ceJls stained with anti-Mo2 reagent. In Table 2 below, numbers in parentheses indicate the "-fold" increase in specific fluorescence intensity of either PFS-stimulated intravascular PMNs or elicited peritoneal PMNs, as compared to unstimulated intravascular PMNs maintained at 4~ The statistical significance of variations in the absolute PMN counts or in the stimulated increases in specific fluorescence intensity were evaluated by Student's t test.
RESULTS
In examining neutrophil responses to localized inflammation in the rat, we first measured the number of PMNs recruited to the peritoneal cavity as a function of time, following the instillation of a local inflammatory agent [sterile 1%
(w/v) glycogen solution]. As shown in Table 1 , there was a profound rise in "For each experiment (N = 5), five rats were injected intraperitoneally with 30 ml sterile 1% glycogen solution. Thereafter, at 1, 2, 3, 4, and 16 h following the injection, one rat was killed for the collection of accumulated peritoneal and intmvascular PMNs, as described in Materials and Methods. Each experiment also included a control animal (not injected with glycogen) from which blood was similarly obtained at time 0. For all peritoneal and intravascular specimens, total leukocyte counts were determined on cell suspensions examined in a standard hemacytometer, and differential leukocyte counts were determined morphologically using Wright-Giemsa stained slide preparations. the mean absolute peritoneal PMN count that was directly related to the duration of the inflammatory exposure. Whereas in normal rats there were negligible numbers of resident peritoneal PMNs (time 0), after 1 and 16 h there were mean total peritoneal PMN counts of 2.1 and 212.0 • 106, respectively, signifying a 100-fold increase over this time interval. In contrast, there was no significant variation over time in the mean intravascular PMN count, Additionally, as shown in Table 1 , we observed that within 2-3 h of intraperitoneal glycogen injection, over 90% of the accumulated leukocytes were PMNs, whereas the percentage of intravascular PMNs did not vary appreciably over time. These results indicate that in this in vivo model of localized (intraperitoneal) inflammation, there was a rapid, marked, and reproducible accumulation of PMNs that was not accompanied by changes in the PMN count of the circulating, intravascular leukocyte pool.
To assess the relative state of activation of rat PMNs in the intravascular and peritoneal compartments, we examined the surface expression of the CD1 tb/CD18 (Mol) glycoprotein, which is an adhesion-promoting molecule whose density on the PMN plasma membrane is up-modulated by exposure to inflammatory factors (t0) and may play a role in the diapedesis and directed migration of PMNs responding to an inflammatory stimulus. In the immunofluorescence analysis shown in Table 2 , surface Mot expression by isolated peritoneal PMNs was significantly increased as compared to intravascular PMNs kept unstimulated at 4~
This increase in specific fluorescence intensity (SFI) above that of unstimulated intravascular PMNs isolated simultaneously ranged from 4.3-to 8.6-fold over the first 4 h (P = NS, <0.01, <0.01, and <0.05, for 1, 2, 3, and 4 h, respectively) and was of lesser magnitude after 16 h. We detected no significant variation over time in the "baseline" SFI of unstimulated intravascular PMNs. However, as shown in Table 2 , these isolated intra- ~Peritoneal and intravascular PMNs (N = 5) were coliected as described in Table 1 , footnote a. Isolated peritoneal PMNs were maintained at 4~ whereas isolated intravascular PMNs were either kept at 4~ or exposed to cell-free peritoneal fluid supematant (PFS, prepared in Materials and Methods) at 37~ for 30 rain, PMNs were then stained by indirect immunofluorescence for the expression of the Mol (CD1 lb) determinant, relative to the background staining by an isotypeidentical negative-control antibody. Table 2 , footnote b). Collectively, these results demonstrate that an increase in the surface expression of the Mol adhesion glycoprotein is a feature characteristic of PMNs recruited from the intravascular leukocyte pool to sites of acute inflammation.
DISCUSSION
Since the accumulation of PMNs at sites of inflammation in vivo is dependent upon several adhesion-related processes (e.g., margination, diapedesis, and directed migration), in this study we sought to characterize the relationship between the inflammatory recruitment of PMNs and their surface expression of the adhesion-promoting plasma membrane glycoprotein, Mol. Mol (CDllb/ CD 18; CR3; gp 155,95) is a member of the CD 11/CD 18 family of structurally related heterodimers expressed on the surfaces of PMNs and certain mononuclear phagocytes (10) and has been shown to promote multiple cellular adhesive interactions, including PMN adherence and spreading on artificial (25, 28) and cellular (29, 30) substrates, aggregation (14, 28, 29) , chemotaxis (25, 28) , and binding of C3bi-opsonized particles (31-33) and gram-negative bacteria (34) . The Mol glycoprotein exists in an intracellular pool associated with secondary and/or tertiary granules (16, 20, 35) and is rapidly translocated to the plasma membrane upon exposure of the cell to a variety of activating factors [e.g., FMLP (12, 13) , C5a (14-16), LTB4 (17, 18) , ATP (19) , PMA and A23187 (12, 20, 21) , and others], thus serving as an "activation marker" for PMNs.
We have found that PMNs accumulating at sites of acute inflammation in vivo do indeed significantly up-modulate their surface density of the Mol antigen, as compared to intravascular PMNs isolated simultaneously from the same animal. Moreover, we have shown that this enhancement occurs rapidly (within 1 h of recruitment), is sustained with further local recruitment of PMNs, and is not accompanied by significant elevations of either the Mol expression or the total count of intravascular PMNs. Thus, our findings extend the observations of Zimmerli et al. (5), who reported a twofold increase in surface Mol expression by exudative guinea pig and human PMNs analyzed at a single time point (14 h) following the introduction of an inflammatory stimulus.
Since Mol up-modulation coincided with PMN accumulation at the site of peritoneal inflammation, we evaluated the possibility that the administration of specific anti-Mol monoclonal antibody might interfere with this process. However, when a simitar group of rats were pretreated (1 mg intravenously 1 h before glycogen injection) with a murine anti-human Mol antibody (clone 17 producing an IgM antibody cross-reacting with the rat homolog), there was no significant reduction in intmperitoneal PMN accumulation 4 h after glycogen injection (despite the presence of saturating concentrations of anti-Mol antibody in the plasma and peritoneal fluid), as compared to negative control rats receiving no antibody (113 _ 10 vs. 106 -L-_ 5 • 106, respectively; mean total peritoneal PMN count _+ SD, N = 3). This is in contrast to the findings of Rosen and Gordon (36) , who recently reported a 75% inhibition of myelomonocytic cell accumulation in a murine model of sterile peritonitis where mice were pretreated with an anti-Mol antibody. The discrepancy in these results is most likely due to a difference in epitope recognition in which one antibody but not the other competitively binds to a region of the Mol glycoprotein that promotes PMN adhesive interactions critical to inflammatory recruitment in vivo (25, 28, 29) . The importance of the CDll/CD18 family of adhesion glycoproteins in PMN migration to inflammatory loci has been indicated by the inhibitory effects of other CDll/CD18-specific monoclonal reagents in several additional animal models of acute inflammation (37) (38) (39) (40) (41) .
While some degree of surface Mol expression is required for normal PMN adhesive function in the inflammatory response, the functional importance of the increase in receptor density above baseline exhibited by activated cells is unclear. The physiologic significance of enhanced Mol expression is suggested by its detection in the settings of clinically active systemic lupus erythematosus (22) , hemodialysis leukopenia (14), severe burns (23) , and the treatment of cancer patients with intravenous GM-CSF (24) . However, a series of recent observations suggest that qualitative, rather than quantitative, changes in existing plasma membrane Mol receptors could underlie the enhanced cellular adhesiveness observed in stimulated PMNs. Wright and coworkers reported the activation and deactivation of CR3 (Mol) binding activity in human PMNs and monocytes without a corresponding change in receptor number (42, 43) . More recently, Vedder and Harlan described increased adherence of human PMNs to cultured endothelial cell monolayers that was independent of the enhancement of CDItb or CD18 determinants detected on PMNs stimulated by PMA, A23187, or FMLP (44) . In addition, Buyon et al. reported that maximal FMLPstimulated aggregation of human PMNs did not correspond to increases in surface Mol expression (45) . Examples of qualitative changes in the Mol receptor that might confer functional responsiveness include topographic clustering of CR3 receptors on the plasma membrane (46, 47) or glycoprotein phosphorylation (43, 48) . Thus, the well-documented inhibitory effect of certain anti-Mol monoclonal reagents on the recruitment of PMNs to inflammatory loci in vivo (36) (37) (38) (39) (40) (41) could be due to an interference with such qualitative changes. If true, the enhancement of Mol expression by PMNs recruited during inflammation, as reported here, may serve a purpose yet to be elucidated.
